O
Olema Pharmaceuticals, Inc.
OLMA · NASDAQ · Healthcare · 929M
Closing price
$7.82
+0.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.4×
Enterprise value / EBITDAEV/EBITDA
-3.9×
Free cash flow yieldFCF yield
-21.6%
Return on equityROE
-33.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.